Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I weekly NK105 in advanced solid tumors
jRCT2080221196Phase 1
- Sponsor
- Nippon Kayaku Co., Ltd.
- Start
- Aug 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NK105 in Non-hematologic malignancy, sponsored by Nippon Kayaku Co., Ltd.
02
Drugs
NK105
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2080221196.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221196.